News and Press Releases
The Barts Life Sciences Cluster Launches in Whitechapel, East London
With planned investment of over £800m, the Cluster brings together Barts Health NHS Trust and private investors to unite clinical excellence and commercial innovation Science Minister Lord Vallance said: “we...
Category: Other, Pharmaceutical
Posted: November 25, 2025
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria
Sanofi and Regeneron’s Dupixent approved as the first targeted medicine in the EU in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies showing Dupixent significantly...
Category: Drug Discovery, Other, Pharmaceutical
Posted: November 25, 2025
The Charter Building, Vine Street, Uxbridge, Middlesex, United Kingdom, UB8 1JG
Chancellor Friedrich Merz Visits Sonotec – High-Tech Ultrasound Technology “Made in Halle (Saale)” in the Center of His Inaugural Visit
As part of his official inaugural visit to Saxony-Anhalt, German Chancellor Friedrich Merz visited the headquarters of SONOTEC GmbH in Halle (Saale) on Tuesday, November 18, 2025. He was accompanied...
Category:
Posted: November 24, 2025
Clinigen finalises acquisition of SSI Strategy
London, UK – 21 November 2025 – Clinigen, the global pathfinder accelerating patient access to critical medicines across the lifecycle, today confirmed the close of its acquisition of SSI Strategy,...
Category:
Posted: November 21, 2025
Science Based Targets Initiative confirms CO2e Reduction Targets
Duesseldorf, November 18, 2025 – Gerresheimer, an innovative system and solution provider and a global partner for the pharma, biotech and cosmetic industries, has had its climate targets validated by...
Category:
Posted: November 19, 2025
Food & Farm for Health Project: Building Smarter Air Cargo for Humanitarian Impact
Data-driven air cargo solutions are unlocking new pathways for health, food security, and local empowerment—optimizing pharmaceutical and perishable supply chains to deliver life-saving medicines, strengthen resilience, and support communities, both...
Category:
Posted: November 19, 2025
Bedrijvenzone Machelen Cargo 706 (mailbox 92) 4th floor, Room 411 B - 1830 Machelen
Ypsomed grows by 21% in the first half of 2025/26 in the core business
Burgdorf – Ypsomed continued on its growth trajectory in the first half of the 2025/26 financial year, the Delivery Systems business reached CHF 266.6 million of sales. This represents a 21.0% increase...
Category:
Posted: November 19, 2025
Alzheon to Present Multiple Clinical, Neuroimaging and Modeling Results for Oral Valiltramiprosate/ALZ-801 from Phase 2 and 3 Studies at CTAD Conference in San Diego, December 1–4, 2025
Valiltramiprosate Demonstrates Potential as the First Oral Disease-Modifying Agent to Slow Alzheimer’s Pathology, Indicated by Both Clinical and Volumetric MRI Data Nine Posters Showcase Consistent Benefits of Oral Valiltramiprosate in...
Category: Biotechnology, Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 19, 2025
Annovis Announces FDA Meeting to Discuss Parkinson’s Disease Dementia Program; Reaffirms FDA Alignment on Pivotal Phase 3 Alzheimer’s Disease Study
18 November 2025 -- Pennsylvania, US -- Annovis Bio, Inc, a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: November 18, 2025
Stratasys Digital Anatomy Technology Powers First 3D-Printed Eyelid Surgery Training Models in Europe
Addion and the University of Innsbruck advance surgical education with life-like anatomical models that enhance the skill sets of medical professionals and improve patient outcomes 18 November 2025 -- Minnesota,...
Category: Biotechnology, Other, Pharmaceutical
Posted: November 18, 2025
ONWARD Medical Receives FDA 510(k) Clearance Expanding ARC-EX System Indication for Home Use
US FDA clearance now allows use of the ARC-EX System both in clinics and homes ARC-EX is the first and only FDA-cleared technology demonstrated to improve hand strength and sensation...
Category: Biotechnology, Other, Pharmaceutical
Posted: November 17, 2025
Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression
Montreal, Canada —Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical...
Category:
Posted: November 14, 2025
Smurfit Westrock unveils new clinical packaging facility at Dublin Airport
Smurfit Westrock has inaugurated the first-of-its-kind adherence and clinical packaging facility, reinforcing Ireland’s role at the forefront of global healthcare. Over 40m euros was invested in the brand-new site, which...
Category:
Posted: November 13, 2025
Eisai presents 4-year Leqembi (lecanemab) open-label extension data from post-hoc sub-group analysis at German neurology congress
Clarity AD open-label extension data show that after four years of continuous lecanemab treatment in apolipoprotein E ε4 (ApoE ε4*) non-carriers and heterozygotes, patients continued to accrue benefit relative to...
Category: Clinical Trials, Other, Pharmaceutical
Posted: November 12, 2025
CARBOGEN AMCIS Announces Successful Refinancing and Enhancement of their Syndicated Credit Facilities to Support Continued Growth and Investment
12 November 2025 -- Bubendorf, Switzerland -- CARBOGEN AMCIS, a subsidiary of Dishman Carbogen Amcis, and a global top-tier Contract Development and Manufacturing Organisation (CDMO), today announced the successful refinancing and...
Category: BioManufacturing, Manufacturing and Packing, Other, Pharmaceutical
Posted: November 12, 2025
